Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10878)
All Articles published online
|
Publishing Process of This Article
|
Oct 10, 2014 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vescovo VD, Grasso M, Barbareschi M, Denti MA. MicroRNAs as lung cancer biomarkers. World J Clin Oncol 2014; 5(4): 604-620 [PMID: 25302165 DOI: 10.5306/wjco.v5.i4.604] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i4/604.htm |
| Number | Citing Articles |
| 1 |
Chang’e Jin, Liang Xiao, Zeqiang Zhou, Yan Zhu, Geng Tian, Shuhua Ren. MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma. Human Cell 2019; 32(4): 437 doi: 10.1007/s13577-019-00258-0
|
| 2 |
Xin Wang, Yi Zhang, Xiuyi Zhi. Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with Non‐small cell Lung Cancer: A retrospective study. Thoracic Cancer 2017; 8(5): 511 doi: 10.1111/1759-7714.12480
|
| 3 |
MEI SUN, SHUNMING HONG, WENHAN LI, PENGFEI WANG, JINQIANG YOU, XUEBIN ZHANG, FAN TANG, PING WANG, CHUNZHI ZHANG. miR-99a regulates ROS-mediated invasion and migration of lung adenocarcinoma cells by targeting NOX4. Oncology Reports 2016; 35(5): 2755 doi: 10.3892/or.2016.4672
|
| 4 |
Wenhui Yang, Chengcheng Zhou, Mei Luo, Xuejiao Shi, Yuan Li, Zengmiao Sun, Fang Zhou, Zhaoli Chen, Jie He. MiR-652-3p is upregulated in non-small cell lung cancer and promotes proliferation and metastasis by directly targeting Lgl1. Oncotarget 2016; 7(13): 16703 doi: 10.18632/oncotarget.7697
|
| 5 |
Duo Li, Dong-Qiong Li, Dan Liu, Xiao-Jun Tang. MiR-613 induces cell cycle arrest by targeting CDK4 in non-small cell lung cancer. Cellular Oncology 2016; 39(2): 139 doi: 10.1007/s13402-015-0262-4
|
| 6 |
Mareen Matz, Christine Lorkowski, Katharina Fabritius, Pawel Durek, Kaiyin Wu, Birgit Rudolph, Hans-H. Neumayer, Mir-Farzin Mashreghi, Klemens Budde. Free microRNA levels in plasma distinguish T-cell mediated rejection from stable graft function after kidney transplantation. Transplant Immunology 2016; 39: 52 doi: 10.1016/j.trim.2016.09.001
|
| 7 |
FENG-YI ZHAO, JING HAN, XIE-WAN CHEN, JIANG WANG, XU-DONG WANG, JIAN-GUO SUN, ZHENG-TANG CHEN. miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor. International Journal of Molecular Medicine 2016; 38(1): 183 doi: 10.3892/ijmm.2016.2588
|
| 8 |
Devan Umapathy, Mano Chitra Karthikeyan, Kumar Ponnuchamy, Antony Joseph Velanganni Arockiam. Transcriptional expression of miRNAs under glucose depletion/2-deoxy-d-glucose in HCC: A possible genetic footprints of angiogenesis and its hallmarks. Gene Reports 2021; 24: 101277 doi: 10.1016/j.genrep.2021.101277
|
| 9 |
Wei Gu. Expression and Significance of Circulating MicroRNA-31 in Lung Cancer Patients. Medical Science Monitor 2015; 21: 722 doi: 10.12659/MSM.893213
|
| 10 |
Guo‐hao Huang, Hong Shan, Dan Li, Bin Zhou, Peng‐fei Pang. MiR‐199a‐5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma. Cell Biochemistry and Function 2017; 35(2): 98 doi: 10.1002/cbf.3252
|
| 11 |
Samar A. Mansour, Amgad A. Farhat, Ayman H. Abd El-Zaher, Adel S. Bediwy, Said M. Abdou, Ayman A. Al Saka, Abdel Aziz A. Zidan. MicroRNA genetic signature in non-small cell lung cancer (NSCLC) Egyptian patients. The Egyptian Journal of Bronchology 2020; 14(1) doi: 10.1186/s43168-020-00021-2
|
| 12 |
M. A. Tennis, M. L. New, D. G. McArthur, D. T. Merrick, L. D. Dwyer-Nield, R. L. Keith. Prostacyclin reverses the cigarette smoke-induced decrease in pulmonary Frizzled 9 expression through miR-31. Scientific Reports 2016; 6(1) doi: 10.1038/srep28519
|
| 13 |
Olga D’Almeida, Omar Mothar, Esther Apraku Bondzie, Yolande Lieumo, Laure Tagne, Sumeet Gupta, Thomas Volkert, Stuart Levine, Jean-Bosco Tagne. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5337-6
|
| 14 |
Grit Rehbein, Bernd Schmidt, Michael Fleischhacker. Extracellular microRNAs in bronchoalveolar lavage samples from patients with lung diseases as predictors for lung cancer. Clinica Chimica Acta 2015; 450: 78 doi: 10.1016/j.cca.2015.07.027
|
| 15 |
Ege Riza Karagur, Sakir Akgun, Hakan Akca. miRNomics. Methods in Molecular Biology 2022; 2257: 349 doi: 10.1007/978-1-0716-1170-8_17
|
| 16 |
Dong Lan, Xin Zhang, Rongquan He, Ruixue Tang, Ping Li, Qiancheng He, Gang Chen. MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance. European Journal of Medical Research 2015; 20(1) doi: 10.1186/s40001-015-0139-z
|
| 17 |
Fei Han, Jinxi He, Feng Li, Jiali Yang, Jun Wei, William C. Cho, Xiaoming Liu. Emerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung Cancer. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/672759
|
| 18 |
Luca Ferrari, Michele Carugno, Carolina Mensi, Angela Cecilia Pesatori. Circulating Epigenetic Biomarkers in Malignant Pleural Mesothelioma: State of the Art and critical Evaluation. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00445
|
| 19 |
Michele Castelluzzo, Alessio Perinelli, Simone Detassis, Michela Alessandra Denti, Leonardo Ricci. MiRNA-QC-and-Diagnosis: An R package for diagnosis based on MiRNA expression. SoftwareX 2020; 12: 100569 doi: 10.1016/j.softx.2020.100569
|
| 20 |
Guo‑Jun Geng, Ying‑Tao Yang, Jie Jiang, Xiu‑Yi Yu, Xian‑En Fa. MicroRNA‑30a suppresses non‑small‑cell lung cancer by targeting Myb‑related protein B. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5559
|
| 21 |
Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, Abdollah Allahverdi. Epigenetic regulation in lung cancer. MedComm 2023; 4(6) doi: 10.1002/mco2.401
|
| 22 |
Jianhong Zuo, Meiling Wen, Mingsheng Lei, Xiaojun Xiao, Zhigang Liu. WITHDRAWN: PLGA-Der p1 Vaccine Inhibited Tumor Growth in a Murine Model of Lung Cancer. Archives of Medical Research 2015; doi: 10.1016/j.arcmed.2015.12.005
|
| 23 |
Tongfei Wang, Wei Li, Haitao Li, Weina Li. Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients. Saudi Journal of Biological Sciences 2021; 28(3): 1561 doi: 10.1016/j.sjbs.2021.01.013
|
| 24 |
Lai Wei, Fengming Ran. MicroRNA-20a promotes proliferation and invasion by directly targeting early growth response 2 in non‑small cell lung carcinoma. Oncology Letters 2017; doi: 10.3892/ol.2017.7299
|
| 25 |
Xiaonian Cao, Senyan Lai, Fayong Hu, Guodong Li, Guihua Wang, Xuelai Luo, Xiangning Fu, Junbo Hu. miR-19a contributes to gefitinib resistance and epithelial mesenchymal transition in non-small cell lung cancer cells by targeting c-Met. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-01153-0
|
| 26 |
Leonardo Ricci, Valerio Del Vescovo, Chiara Cantaloni, Margherita Grasso, Mattia Barbareschi, Michela Alessandra Denti. Statistical analysis of a Bayesian classifier based on the expression of miRNAs. BMC Bioinformatics 2015; 16(1) doi: 10.1186/s12859-015-0715-9
|
| 27 |
Fenghe Cui, Qian Zhou, Kuang Xiao, Haiyun Qian. MicroRNA‑28 promotes the proliferation of non‑small‑cell lung cancer cells by targeting PTEN. Molecular Medicine Reports 2020; doi: 10.3892/mmr.2020.11033
|
| 28 |
Aijia Zhang, Xuexing Luo, Yu Li, Lunchun Yan, Xin Lai, Qianxu Yang, Ziming Zhao, Guanghui Huang, Zheng Li, Qibiao Wu, Jue Wang. Epigenetic changes driven by environmental pollutants in lung carcinogenesis: a comprehensive review. Frontiers in Public Health 2024; 12 doi: 10.3389/fpubh.2024.1420933
|
| 29 |
Luigina Micolucci, Most Mauluda Akhtar, Fabiola Olivieri, Maria Rita Rippo, Antonio Domenico Procopio. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis. Oncotarget 2016; 7(36): 58606 doi: 10.18632/oncotarget.9686
|
| 30 |
Weijia Xie, Shuai Yuan, Zhifu Sun, Yafei Li. Long Noncoding and Circular RNAs in Lung Cancer: Advances and Perspectives. Epigenomics 2016; 8(9): 1275 doi: 10.2217/epi-2016-0036
|
| 31 |
Anne C. Emmerich, Julia Wellstein, Elena Ossipova, Isabell Baumann, Johan Lengqvist, Kim Kultima, Per-Johan Jakobsson, Dieter Steinhilber, Meike J. Saul. Proteomics-Based Characterization of miR-574-5p Decoy to CUGBP1 Suggests Specificity for mPGES-1 Regulation in Human Lung Cancer Cells. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00196
|
| 32 |
Patrycja Paciorek, Mariusz Żuberek, Agnieszka Grzelak. Rola miRNA w rozwoju wybranych nowotworów – potencjalne zastosowanie w diagnostyce*. Postępy Higieny i Medycyny Doświadczalnej 2021; 75(1): 1 doi: 10.5604/01.3001.0014.6578
|
| 33 |
Vladimir Gligorijević, Noël Malod‐Dognin, Nataša Pržulj. Integrative methods for analyzing big data in precision medicine. PROTEOMICS 2016; 16(5): 741 doi: 10.1002/pmic.201500396
|
| 34 |
Ayda Arab, Morteza Karimipoor, Shiva Irani, Arda Kiani, Sirous Zeinali, Elham Tafsiri, Kambiz Sheikhy. Potential circulating miRNA signature for early detection of NSCLC. Cancer Genetics 2017; : 150 doi: 10.1016/j.cancergen.2017.07.006
|
| 35 |
X. Ding, Y. Yang, Y. Sun, W. Xu, B. Su, X. Zhou. MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1. Clinical and Translational Oncology 2017; 19(5): 546 doi: 10.1007/s12094-016-1562-5
|
| 36 |
Xiaoyuan Du, Zhijing Wang, Xia Liu, Xueying Liu, Yuanyuan Wang. Withdrawn: The effects of MiR-223 on the sensitivity of non-small cell lung cancer cells to erlotinib and its underlying mechanisms. Saudi Pharmaceutical Journal 2017; doi: 10.1016/j.jsps.2017.04.031
|
| 37 |
Qing-Qing Tian, Jing Xia, Xin Zhang, Bao-Qin Gao, Wei Wang. <p>miR-331-3p Inhibits Tumor Cell Proliferation, Metastasis, Invasion by Targeting MLLT10 in Non-Small Cell Lung Cancer</p>. Cancer Management and Research 2020; : 5749 doi: 10.2147/CMAR.S249686
|
| 38 |
Monika Migdalska-Sęk, Barbara Modrzewska, Jacek Kordiak, Dorota Pastuszak-Lewandoska, Justyna M. Kiszałkiewicz, Filip Bielec, Adam Antczak, Ewa Brzeziańska-Lasota. Diagnostic value of PPARδ and miRNA-17 expression levels in patients with non-small cell lung cancer. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-03312-w
|
| 39 |
Miranda B. Carper, Pier Paolo Claudio. Clinical potential of gene mutations in lung cancer. Clinical and Translational Medicine 2015; 4(1) doi: 10.1186/s40169-015-0074-1
|
| 40 |
Zoltán Nagy, Peter Igaz. Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance. Experientia Supplementum 2015; 106: 3 doi: 10.1007/978-3-0348-0955-9_1
|
| 41 |
Marios A. Diamantopoulos, Panagiotis G. Adamopoulos, Andreas Scorilas. Small non-coding RNAs as diagnostic, prognostic and predictive biomarkers of gynecological cancers: an update. Expert Review of Molecular Diagnostics 2024; 24(11): 979 doi: 10.1080/14737159.2024.2408740
|
| 42 |
Yongyong Xi, Liang wang, Chengcao Sun, Cuili Yang, Feng Zhang, Dejia Li. The novel miR-9501 inhibits cell proliferation, migration and activates apoptosis in non-small cell lung cancer. Medical Oncology 2016; 33(11) doi: 10.1007/s12032-016-0837-6
|
| 43 |
Xiaori Huang, Lei Wang, Wei Liu, Fei Li. MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2. Oncology Letters 2019; doi: 10.3892/ol.2019.9954
|
| 44 |
Ming-Jenn Chen, De-Wei Wu, Gao-Chang Wang, Yao-Chen Wang, Chi-Yi Chen, Huei Lee. MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2. Oncotarget 2018; 9(17): 13758 doi: 10.18632/oncotarget.24474
|
| 45 |
Christian Rolfo, Jorge Chacártegui Borrás, Marco Giallombardo. Molecular Targets and Strategies in Cancer Prevention. 2016; : 85 doi: 10.1007/978-3-319-31254-5_5
|
| 46 |
Mohammad Yazdanpour, Saeid Rahmani, Hadi Bayat, Hanifeh Mirtavoos-Mahyari, Adnan Khosravi, Seyed Javad Mowla. Non-invasive discrimination of adenocarcinoma and squamous cell carcinoma based on differential expression of miR-944 and miR-326 in sputum samples of lung cancer patients. Human Gene 2024; 40: 201273 doi: 10.1016/j.humgen.2024.201273
|
| 47 |
Pichitpon Chaniad, Keson Trakunram, Sarayut Lucien Geater, Warangkana Keeratichananont, Paramee Thongsuksai, Pritsana Raungrut. Association of Serum miR-145 with Vascular Endothelial Growth Factor (VEGF) in Patients with Non-Small Cell Lung Cancer. Proceedings of the 2017 4th International Conference on Biomedical and Bioinformatics Engineering 2017; : 97 doi: 10.1145/3168776.3168788
|
| 48 |
Tianze Zhang, Yingying Hu, Jin Ju, Liangyu Hou, Zhange Li, Dan Xiao, Yongchao Li, Jianyu Yao, Chao Wang, Yong Zhang, Linyou Zhang. Downregulation of miR-522 suppresses proliferation and metastasis of non-small cell lung cancer cells by directly targeting DENN/MADD domain containing 2D. Scientific Reports 2016; 6(1) doi: 10.1038/srep19346
|
| 49 |
Meng Zhou, Wanying Xu, Xiaolong Yue, Hengqiang Zhao, Zhenzhen Wang, Hongbo Shi, Liang Cheng, Jie Sun. Relapse-related long non-coding RNA signature to improve prognosis prediction of lung adenocarcinoma. Oncotarget 2016; 7(20): 29720 doi: 10.18632/oncotarget.8825
|
| 50 |
W Ma, C-n Ma, X-d Li, Y-j Zhang. Examining the effect of gene reduction in miR-95 and enhanced radiosensitivity in non-small cell lung cancer. Cancer Gene Therapy 2016; 23(2-3): 66 doi: 10.1038/cgt.2016.2
|
| 51 |
Bethina da Rocha Camargo, Vanessa das Graças Pereira De Souza, Rainer Marco López Lapa, Patricia Pintor Dos Reis, Rogério Antonio Oliveira. A DECISION TREE-BASED CLASSIFIER COMPARES THREE DATA ANALYSIS METHODS FOR THE IDENTIFICATION OF MIRNAS ASSOCIATED WITH EARLY-STAGE LUNG CANCER. REVISTA FOCO 2023; 16(5): e2031 doi: 10.54751/revistafoco.v16n5-137
|
| 52 |
Wei Liu, Xiuwei Wan, Zongyun Mu, Fei Li, Lei Wang, Jing Zhao, Xiaori Huang. MiR-1256 suppresses proliferation and migration of non-small cell lung cancer via regulating TCTN1. Oncology Letters 2018; doi: 10.3892/ol.2018.8794
|
| 53 |
Tianci Song, Yanchun Liang, Zhongbo Cao, Wei Du, Ying Li. Computational Analysis of Specific MicroRNA Biomarkers for Noninvasive Early Cancer Detection. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/4680650
|
| 54 |
Xu Bai, Hui Chen, Brian G. Oliver. miRNAs-mediated overexpression of Periostin is correlated with poor prognosis and immune infiltration in lung squamous cell carcinoma. Aging 2022; 14(9): 3757 doi: 10.18632/aging.204056
|
| 55 |
Peixia Yang, Jie Xiong, Lin Zuo, Kequn Liu, Houbin Zhang. miR‑140‑5p regulates cell migration and invasion of non‑small cell lung cancer cells through targeting VEGFA. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9291
|
| 56 |
Elham O. Mahgoub, Ehsan Razmara, Amirreza Bitaraf, Fahimeh-Sadat Norouzi, Maryam Montazeri, Roudabeh Behzadi-Andouhjerdi, Mojtaba Falahati, Ke Cheng, Yousif Haik, Anwarul Hasan, Sadegh Babashah. Advances of exosome isolation techniques in lung cancer. Molecular Biology Reports 2020; 47(9): 7229 doi: 10.1007/s11033-020-05715-w
|
| 57 |
Bryant C. Yung, Jilong Li, Mengzi Zhang, Xinwei Cheng, Hong Li, Elaine M. Yung, Chen Kang, Lauren E. Cosby, Yang Liu, Lesheng Teng, Robert J. Lee. Lipid Nanoparticles Composed of Quaternary Amine–Tertiary Amine Cationic Lipid Combination (QTsome) for Therapeutic Delivery of AntimiR-21 for Lung Cancer. Molecular Pharmaceutics 2016; 13(2): 653 doi: 10.1021/acs.molpharmaceut.5b00878
|
| 58 |
Hitoshi Dejima, Hisae Iinuma, Rie Kanaoka, Noriyuki Matsutani, Masafumi Kawamura. Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer. Oncology Letters 2017; 13(3): 1256 doi: 10.3892/ol.2017.5569
|
| 59 |
Limin Xu, Xuting Xu, Huilian Huang, Zhihong Ma, Shuangmei Zhang, Pingping Niu, Yingrong Chen, Jinliang Ping, Ping Lu, Caihua Yu, Lishan Min, Jing Chen, Licheng Dai, Shunli Dong. MiR-1260b promotes the migration and invasion in non-small cell lung cancer via targeting PTPRK. Pathology - Research and Practice 2018; 214(5): 776 doi: 10.1016/j.prp.2018.02.002
|
| 60 |
Radu Pirlog, Paul Chiroi, Ioana Rusu, Ancuta Maria Jurj, Liviuta Budisan, Cecilia Pop-Bica, Cornelia Braicu, Doinita Crisan, Jean-Christophe Sabourin, Ioana Berindan-Neagoe. Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer. International Journal of Molecular Sciences 2022; 23(10): 5346 doi: 10.3390/ijms23105346
|
| 61 |
Weronika Świtlik, Michał Seweryn Karbownik, Michał Suwalski, Józef Kozak, Janusz Szemraj. miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study. Cancer Biomarkers 2018; 21(2): 479 doi: 10.3233/CBM-170767
|
| 62 |
Dana Al Sulaiman, Nidhi Juthani, Patrick S. Doyle. Quantitative and Multiplex Detection of Extracellular Vesicle‐Derived MicroRNA via Rolling Circle Amplification within Encoded Hydrogel Microparticles. Advanced Healthcare Materials 2022; 11(10) doi: 10.1002/adhm.202102332
|
| 63 |
Meike J. Saul, Isabell Baumann, Annalisa Bruno, Anne C. Emmerich, Julia Wellstein, Sarah M. Ottinger, Annalisa Contursi, Melania Dovizio, Sandra Donnini, Stefania Tacconelli, Joan Raouf, Helena Idborg, Stefan Stein, Marina Korotkova, Rajkumar Savai, Erika Terzuoli, Gianluca Sala, Werner Seeger, Per-Johan Jakobsson, Paola Patrignani, Beatrix Suess, Dieter Steinhilber. miR‐574‐5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES‐1 induction. The FASEB Journal 2019; 33(6): 6933 doi: 10.1096/fj.201802547R
|
| 64 |
Eleonora Zonta, Philippe Nizard, Valérie Taly. . Advances in Clinical Chemistry 2015; 70: 197 doi: 10.1016/bs.acc.2015.03.002
|